BeOne Medicines Honored with the Global Oncology Innovation Leadership Award at BIOHK 2025, Supporting “1+” to Accelerate the Delivery of Innovative Cancer Therapies

HONG KONG SAR – Media OutReach Newswire – 11 September 2025 – BeOne Medicines (BeOne)(NASDAQ: ONC; HKEX: 06160; SSE: 688235), was honored today at BIOHK 2025, the Hong Kong International Biotechnology Conference & Exhibition, with the prestigious Global Oncology Innovation Leadership Award. This award recognizes BeOne’s outstanding contributions to advancing global oncology research and delivering

Read More